Commercializing Living Therapies with CCRM
By CCRM
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by CCRM
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 27
Description
Hear from academic and industry experts sharing insider insights, information and trend forecasts for the cell and gene therapy industry. “Commercializing Living Therapies with CCRM” is brought to you by CCRM, a leader in developing, manufacturing and commercializing regenerative medicine-based technologies, and cell and gene therapies. Questions / comments? email: podcast@ccrm.ca.
| Episode | Date |
|---|---|
|
Breaking down barriers: Bringing advanced therapies to patients worldwide
|
Sep 15, 2026 |
|
The CMC edge: Future-proofing cell and gene therapies for market
|
Aug 14, 2026 |
|
Confronting misinformation in the cell and gene therapies field
|
Jul 15, 2026 |
|
Convergence, collaboration and commercialization in cell and gene therapies
|
May 15, 2025 |
|
Investing in the future of medicine: Trends, hurdles and opportunities in the CGT sector
|
Apr 15, 2025 |
|
Navigating commercialization: Regional hubs, global solutions
|
Mar 15, 2025 |
|
Enabling patient access to cell and gene therapies
|
Feb 15, 2025 |
|
Unapproved stem cell therapies: Risks, realities and responsibilities
|
Jan 15, 2025 |
|
Biomanufacturing redefined: The role of AI and robotics in producing cell and gene therapies
|
Dec 15, 2024 |
|
Expert insights for taking a cell or gene therapy company from vision to reality
|
Apr 15, 2024 |
|
Regulators' strategies for managing the surge in cell and gene therapies
|
Feb 15, 2024 |
|
How Creative Destruction Lab accelerates the advanced therapies industry
|
Jan 15, 2024 |
|
The synergy solution: How public-private partnerships advance regenerative medicine
|
Dec 15, 2023 |
|
Catalysts of change: Canada’s research hubs are shaping the future of biomanufacturing
|
Nov 15, 2023 |
|
From code to cure: Exploring the synergies of artificial intelligence and regenerative medicine
|
Oct 15, 2023 |
|
Stuck in the sixties: The fight to fast-forward access to better cancer treatment
|
Apr 14, 2023 |
|
CAR T therapies: Engineering immune cells to treat cancer
|
Mar 14, 2023 |
|
Protecting the product of innovation: IP and commercialization in cell and gene therapies
|
Feb 14, 2023 |
|
Mentoring: making moves to maximize career growth
|
Jan 15, 2023 |
|
Unlocking the potential of induced pluripotent stem cells
|
Dec 14, 2022 |
|
Training tomorrow’s talent: building the biomanufacturing workforce
|
Nov 14, 2022 |
|
You get what you pay for
|
Jun 14, 2022 |
|
A busy intersection: Ethics and policy in cell and gene therapies
|
May 14, 2022 |
|
The Future’s Synthetic
|
Mar 14, 2022 |
|
Moving from A to B
|
Feb 14, 2022 |
|
Chaperoning innovation through the valley of death
|
Jan 14, 2022 |
|
The importance of educating the public about cell and gene therapies
|
Dec 14, 2021 |